Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224

Diabetes Care. 2024 May 1;47(5):e44-e45. doi: 10.2337/dc24-0055.
No abstract available

MeSH terms

  • Blood Glucose*
  • Diabetes Mellitus, Type 1*
  • Humans
  • Hypoglycemic Agents
  • Patient Reported Outcome Measures

Substances

  • Blood Glucose
  • Hypoglycemic Agents